Targeson is a biotechnology company that develops, manufactures and markets ultrasound contrast agent technologies for pre-clinical molecular imaging in animal models. The company has engineered a versatile microsphere platform that may be used as both a contrast agent and, in a slightly modified form, a drug or gene delivery agent for research applications.
U.Va. Founders: Dr. Klaus Ley, Joshua Rychak